Howard Higley (contractor to CIP to follow these projects) and Carolyn Sigworth (SSA) and Gary Kelloff
endorsed by FDA as biomarker qualification processes.
2 trials:
- Lymphoma collected by OSU Jacko (therapy) under 25 cases thus far.
- ACRIN 6678 Lung, run by Weber, PET CT of the Lung (monitoriing rather than therapy) (maybe some IP issues on data)
Accrual is not close
Three-way FNIH project. Us, FDA, Companies.
These are open trials, need to satisify FNIH "incubation period" security.
Carl will call Higley today.
